Skip to main content
Cancer Explained

Research

Real-World Evidence: HPV Vaccination Is Driving Down Cervical Cancer

Studies now show cervical cancer and precancers falling in vaccinated young women. Here's what the real-world evidence shows about the HPV vaccine.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

What people see in the news

Nearly two decades after HPV vaccination programs began rolling out, studies are now reporting sharp declines in cervical cancer and precancers among the first generations of vaccinated young women. Some coverage has gone so far as to say the vaccine is "erasing" the disease in young women — striking language for a genuinely encouraging trend.

What it actually means

The human papillomavirus (HPV) causes almost all cervical cancers, along with several other cancers. Because it takes years for an HPV infection to progress to cancer, it has taken time to see the vaccine's full effect in cancer rates — and that evidence is now arriving.

Researchers in the U.S. reported in JAMA a steep drop in cervical cancer deaths among women under 25, the group most likely to have been vaccinated. Studies from countries with early, high-uptake programs — such as Sweden and the UK — have found large reductions in invasive cervical cancer and in high-grade precancerous lesions among women vaccinated at young ages. These are real-world results in whole populations, complementing the earlier clinical trials.

This fits what the National Cancer Institute reports about how the vaccine works. NCI states that HPV vaccination is highly effective at preventing infection with the HPV types it targets, and that vaccination before exposure to the virus offers the greatest protection. That's why it's recommended for preteens — before most people are exposed.

What this does and doesn't change

  • The evidence strengthens an already strong case: vaccinating young people prevents HPV infections that can lead to cancer, and the population-level cancer benefit is now becoming visible.
  • Protection is greatest when given before exposure to HPV, which is why the vaccine is recommended in early adolescence.
  • Vaccination does not replace screening. NCI is explicit that because the vaccine doesn't cover every high-risk HPV type, vaccinated people who have a cervix should still follow cervical cancer screening recommendations.
  • The vaccine also helps prevent other HPV-related cancers, not only cervical cancer.

If you're thinking about vaccination or screening for yourself or family, our free screening check-up tool can help, and our guides to the HPV vaccine and cervical cancer screening explain the details.

Questions to ask a healthcare team

  • Is HPV vaccination recommended for my child, or for me?
  • If I wasn't vaccinated as a teen, could I still benefit?
  • Which cervical cancer screening schedule should I follow?
  • What other cancers does HPV vaccination help prevent?

Watching a vaccine translate into fewer cancers is one of the clearer public-health success stories in cancer. Free, plain-language cancer education helps more people understand why prevention like this matters.

Go deeper with NCI

💛 Support free cancer education

Cancer Explained is free for everyone. Donations help us keep creating calm, plain-language explanations based on trusted National Cancer Institute resources.